Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO).

Mikhail AI, Schön S, Simon S, Brown C, Hegbrant JBA, Jensen G, Moore J, Lundberg LDI.

BMC Nephrol. 2019 Jan 10;20(1):13. doi: 10.1186/s12882-018-1159-z.

2.

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial.

Saglimbene V, Palmer SC, Ruospo M, Natale P, Maione A, Nicolucci A, Vecchio M, Tognoni G, Craig JC, Pellegrini F, Lucisano G, Hegbrant J, Ariano R, Lamacchia O, Sasso A, Morano S, Filardi T, De Cosmo S, Pugliese G, Procaccini DA, Gesualdo L, Palasciano G, Johnson DW, Tonelli M, Strippoli GFM; Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators.

J Am Soc Nephrol. 2018 Dec;29(12):2890-2899. doi: 10.1681/ASN.2018040443. Epub 2018 Nov 12.

PMID:
30420421
3.

The Association of Mediterranean and DASH Diets with Mortality in Adults on Hemodialysis: The DIET-HD Multinational Cohort Study.

Saglimbene VM, Wong G, Craig JC, Ruospo M, Palmer SC, Campbell K, Garcia-Larsen V, Natale P, Teixeira-Pinto A, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Strippoli GFM.

J Am Soc Nephrol. 2018 Jun;29(6):1741-1751. doi: 10.1681/ASN.2018010008. Epub 2018 Apr 25.

PMID:
29695436
4.

Person-Centered Integrated Care for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Valentijn PP, Pereira FA, Ruospo M, Palmer SC, Hegbrant J, Sterner CW, Vrijhoef HJM, Ruwaard D, Strippoli GFM.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):375-386. doi: 10.2215/CJN.09960917. Epub 2018 Feb 9.

PMID:
29438975
5.

Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The DIET-HD multinational cohort study.

Saglimbene VM, Wong G, Ruospo M, Palmer SC, Campbell K, Larsen VG, Natale P, Teixeira-Pinto A, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Török M, Bednarek-Skublewska A, Duława J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM.

Clin Nutr. 2019 Feb;38(1):429-437. doi: 10.1016/j.clnu.2017.11.020. Epub 2017 Dec 6.

6.

Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study.

van Zwieten A, Wong G, Ruospo M, Palmer SC, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano L, Murgo M, Loy CT, Tortelli R, Craig JC, Johnson DW, Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GFM; COGNITIVE-HD study investigators.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1197-1206. doi: 10.1093/ndt/gfx314.

PMID:
29186522
7.

The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study.

Saglimbene V, Natale P, Palmer S, Scardapane M, Craig JC, Ruospo M, Gargano L, Lucisano G, Török M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Stroumza P, Leal M, Del Castillo D, Murgo AM, Schon S, Wollheim C, Hegbrant J, Strippoli GFM.

PLoS One. 2017 Jun 20;12(6):e0179511. doi: 10.1371/journal.pone.0179511. eCollection 2017.

8.

Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study.

Ruospo M, Palmer SC, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Del Castillo D, Schon S, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli GF; ORALD Investigators.

BMC Nephrol. 2017 May 22;18(1):166. doi: 10.1186/s12882-017-0574-x.

9.

Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome.

Leion F, Hegbrant J, den Bakker E, Jonsson M, Abrahamson M, Nyman U, Björk J, Lindström V, Larsson A, Bökenkamp A, Grubb A.

Scand J Clin Lab Invest. 2017 Sep;77(5):338-344. doi: 10.1080/00365513.2017.1324175. Epub 2017 May 19.

PMID:
28521564
10.

Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial.

Saglimbene V, Palmer SC, Craig JC, Ruospo M, Nicolucci A, Tonelli M, Johnson D, Lucisano G, Williams G, Valentini M, D'Alonzo D, Pellegrini F, Strippoli P, Salomone M, Santoro A, Maffei S, Hegbrant J, Tognoni G, Strippoli GF; CE-DOSE Study Investigators.

PLoS One. 2017 Mar 1;12(3):e0172735. doi: 10.1371/journal.pone.0172735. eCollection 2017.

11.

Depression and all-cause and cardiovascular mortality in patients on haemodialysis: a multinational cohort study.

Saglimbene V, Palmer S, Scardapane M, Craig JC, Ruospo M, Natale P, Gargano L, Leal M, Bednarek-Skublewska A, Dulawa J, Ecder T, Stroumza P, Marco Murgo A, Schön S, Wollheim C, Hegbrant J, Strippoli GF.

Nephrol Dial Transplant. 2017 Feb 1;32(2):377-384. doi: 10.1093/ndt/gfw016.

PMID:
28186569
12.

Improving outcomes of dialysis patients by population health management-the Global Chief Medical Officer Initiative.

Canaud B, Hegbrant J, Nissenson AR, Barth C, Maddux F, Etter M, Krishnan M.

Lancet. 2016 Oct 22;388(10055):1966-1967. doi: 10.1016/S0140-6736(16)31894-3. No abstract available.

PMID:
27789006
13.

Patterns of oral disease in adults with chronic kidney disease treated with hemodialysis.

Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Frantzen L, Bednarek-Skublewska A, Dulawa J, Del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Schon S, Gargano L, Bots CP, Strippoli GF; ORALD Investigators.

Nephrol Dial Transplant. 2016 Oct;31(10):1647-53. doi: 10.1093/ndt/gfv413. Epub 2015 Dec 29.

PMID:
27035674
14.

COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis.

Palmer SC, Ruospo M, Barulli MR, Iurillo A, Saglimbene V, Natale P, Gargano L, Murgo AM, Loy C, van Zwieten A, Wong G, Tortelli R, Craig JC, Johnson DW, Tonelli M, Hegbrant J, Wollheim C, Logroscino G, Strippoli GF; COGNITIVE-HD Study Investigators.

BMJ Open. 2015 Dec 9;5(12):e009328. doi: 10.1136/bmjopen-2015-009328.

15.

Benefits and implementation of home hemodialysis: A narrative review.

Karkar A, Hegbrant J, Strippoli GF.

Saudi J Kidney Dis Transpl. 2015 Nov;26(6):1095-107. doi: 10.4103/1319-2442.168556. Review.

16.

Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study.

Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, Del Castillo D, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli GF; ORAL-D Study Investigators.

Am J Kidney Dis. 2015 Oct;66(4):666-76. doi: 10.1053/j.ajkd.2015.04.051. Epub 2015 Jun 25.

17.

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study.

Palmer SC, Ruospo M, Campbell KL, Garcia Larsen V, Saglimbene V, Natale P, Gargano L, Craig JC, Johnson DW, Tonelli M, Knight J, Bednarek-Skublewska A, Celia E, Del Castillo D, Dulawa J, Ecder T, Fabricius E, Frazão JM, Gelfman R, Hoischen SH, Schön S, Stroumza P, Timofte D, Török M, Hegbrant J, Wollheim C, Frantzen L, Strippoli GF; DIET-HD Study investigators.

BMJ Open. 2015 Mar 20;5(3):e006897. doi: 10.1136/bmjopen-2014-006897.

18.

Home versus in-centre haemodialysis for end-stage kidney disease.

Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, Leal M, Hoischen S, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Nov 20;(11):CD009535. doi: 10.1002/14651858.CD009535.pub2. Review.

PMID:
25412074
19.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
20.

Patient satisfaction with in-centre haemodialysis care: an international survey.

Palmer SC, de Berardis G, Craig JC, Tong A, Tonelli M, Pellegrini F, Ruospo M, Hegbrant J, Wollheim C, Celia E, Gelfman R, Ferrari JN, Törok M, Murgo M, Leal M, Bednarek-Skublewska A, Dulawa J, Strippoli GF.

BMJ Open. 2014 May 19;4(5):e005020. doi: 10.1136/bmjopen-2014-005020.

21.

Knowing what we do and doing what we should: quality assurance in hemodialysis.

Alquist M, Bosch JP, Barth C, Combe C, Daugirdas JT, Hegbrant JB, Martin G, McIntyre CW, O'Donoghue DJ, Rodriguez HJ, Santoro A, Tattersall JE, Vantard G, Van Wyck DB, Canaud B.

Nephron Clin Pract. 2014;126(3):135-43. doi: 10.1159/000361050. Epub 2014 Apr 15.

PMID:
24751758
22.

Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis.

Mostovaya IM, Blankestijn PJ, Bots ML, Covic A, Davenport A, Grooteman MP, Hegbrant J, Locatelli F, Vanholder R, Nubé MJ; EUDIAL1 – an official ERA-EDTA Working Group.

Semin Dial. 2014 Mar;27(2):119-27. Review.

PMID:
24738146
23.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
24.

Healthcare systems and chronic kidney disease: putting the patient in control.

Ronco C, Mason G, Nayak Karopadi A, Milburn A, Hegbrant J.

Nephrol Dial Transplant. 2014 May;29(5):958-63. doi: 10.1093/ndt/gft457. Epub 2013 Nov 13. Review.

PMID:
24235080
25.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD004289. doi: 10.1002/14651858.CD004289.pub5. Review.

PMID:
24022428
26.

[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial].

Saglimbene V, D'Alonzo D, Ruospo M, Vecchio M, Natale P, Gargano L, Nicolucci A, Pellegrini F, Craig JC, Triolo G, Procaccini DA, Santoro A, Di Giulio S, La Rosa S, Murgo A, Di Toro Mammarella R, Sambati M, D'Ambrosio N, Greco V, Giannoccaro G, Flammini A, Boccia E, Montalto G, Pagano S, Amarù S, Fici M, Lumaga GB, Mancini E, Veronesi M, Patregnani L, Querques M, Schiavone P, Chimienti S, Palumbo R, Di Franco D, Della Volpe M, Gori E, Salomone M, Iacono A, Moscoloni M, Treglia A, Casu D, Piras AM, Di Silva A, Mandreoli M, Lopez A, Quarello F, Catizone L, Russo G, Forcellini S, Maccarone M, Catucci G, Di Paolo B, Stingone A, D'Angelo B, Guastoni C, Pasquali S, Minoretti C, Bellasi A, Boscutti G, Martone M, David S, Schito F, Urban L, Di Iorio B, Caruso F, Mazzoni A, Musacchio R, Andreoli D, Cossu M, Li Cavoli G, Cornacchiari M, Granata A, Clementi A, Giordano R, Guastoni C, Barzaghi W, Valentini M, Hegbrant J, Tognoni G, Strippoli GF.

G Ital Nefrol. 2013 Mar-Apr;30(2). pii: gin/30.2.21. Italian.

PMID:
23832463
27.

Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.

Strippoli GF, Palmer SC, Ruospo M, Natale P, Saglimbene V, Craig JC, Pellegrini F, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Ferrari JN, del Castillo D, Hegbrant J, Wollheim C, Gargano L; ORAL-D Investigators.

BMC Nephrol. 2013 Apr 19;14:90. doi: 10.1186/1471-2369-14-90.

28.

The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study.

Tong A, Palmer S, Manns B, Craig JC, Ruospo M, Gargano L, Johnson DW, Hegbrant J, Olsson M, Fishbane S, Strippoli GF.

BMJ Open. 2013 Jan 24;3(1). pii: e002148. doi: 10.1136/bmjopen-2012-002148.

29.

Clinician beliefs and attitudes about home haemodialysis: a multinational interview study.

Tong A, Palmer S, Manns B, Craig JC, Ruospo M, Gargano L, Johnson DW, Hegbrant J, Olsson M, Fishbane S, Strippoli GF.

BMJ Open. 2012 Dec 12;2(6). pii: e002146. doi: 10.1136/bmjopen-2012-002146. Print 2012.

30.

Sexual dysfunction in women with ESRD requiring hemodialysis.

Strippoli GF; Collaborative Depression and Sexual Dysfunction (CDS) in Hemodialysis Working Group, Vecchio M, Palmer S, De Berardis G, Craig J, Lucisano G, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Hegbrant J, Wollheim C, De Cosmo S, Manfreda VM.

Clin J Am Soc Nephrol. 2012 Jun;7(6):974-81. doi: 10.2215/CJN.12601211. Epub 2012 Apr 5.

31.

Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study.

Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group, Vecchio M, Palmer S, De Berardis G, Craig J, Johnson D, Pellegrini F, Nicolucci A, Sciancalepore M, Saglimbene V, Gargano L, Bonifati C, Ruospo M, Navaneethan SD, Montinaro V, Stroumza P, Zsom M, Torok M, Celia E, Gelfman R, Bednarek-Skublewska A, Dulawa J, Graziano G, Lucisano G, Gentile G, Ferrari JN, Santoro A, Zucchelli A, Triolo G, Maffei S, Hegbrant J, Wollheim C, De Cosmo S, Manfreda VM, Strippoli GF.

Nephrol Dial Transplant. 2012 Jun;27(6):2479-88. doi: 10.1093/ndt/gfr635. Epub 2011 Dec 29.

PMID:
22207325
32.

The quest to standardize hemodialysis care.

Hegbrant J, Gentile G, Strippoli GF.

Contrib Nephrol. 2011;171:39-49. doi: 10.1159/000327338. Epub 2011 May 23. Review.

PMID:
21625088
33.

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.

Navaneethan SD, Hegbrant J, Strippoli GF.

Curr Opin Nephrol Hypertens. 2011 Mar;20(2):146-52. doi: 10.1097/MNH.0b013e3283435f0e. Review.

PMID:
21245764
34.

Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies.

Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GF.

Am J Kidney Dis. 2010 Oct;56(4):670-85. doi: 10.1053/j.ajkd.2010.06.016. Review.

PMID:
20801572
35.

Correlation of treatment time and ultrafiltration rate with serum albumin and C-reactive protein levels in patients with end-stage kidney disease receiving chronic maintenance hemodialysis: a cross-sectional study.

Zsom L, Zsom M, Fülöp T, Wells C, Flessner MF, Eller J, Wollheim C, Hegbrant J, Strippoli GF.

Blood Purif. 2010;30(1):8-15. doi: 10.1159/000314648. Epub 2010 May 20.

PMID:
20484902
36.

Monitor turnaround time and time efficiency in hemodialysis delivery--a global comparison.

Alquist M, Hegbrant JB, Bosch JP.

Blood Purif. 2009;28(3):234-8. doi: 10.1159/000231987. Epub 2009 Aug 14.

PMID:
19684389
37.

Dose requirements among hemodialysis patients treated with darbepoetin-alpha or epoetin-beta.

Prata MM, Dos Santos JP, Hegbrant J, Schmid CH, Pereira BJ, Wald R.

Nephron Clin Pract. 2007;107(2):c50-5. Epub 2007 Aug 21.

PMID:
17713351
38.

A theoretical investigation of the supersaturation of basic calcium phosphate in serum of dialysis patients.

Sandin K, Hegbrant J, Kloo L.

J Appl Biomater Biomech. 2006 May-Aug;4(2):80-6.

PMID:
20799206
39.

The postdialytic rise in the plasma total homocysteine concentration is delayed.

Arnadottir M, Wingren K, Hultberg B, Hegbrant J.

Blood Purif. 2002;20(4):334-7.

PMID:
12169841
40.

Practical approach to data collection in a European dialysis network.

Hegbrant J, Alper A, Bosch JP.

Contrib Nephrol. 2002;(137):287-92. No abstract available.

PMID:
12101967
41.

Evidence of calcium phosphate depositions in stenotic arteriovenous fistulas.

Olsson LF, Odselius R, Ribbe E, Hegbrant J.

Am J Kidney Dis. 2001 Aug;38(2):377-83.

PMID:
11479165
42.

Development of a urea concentration gradient between muscle interstitium and plasma during hemodialysis.

Alquist M, Thysell H, Ungerstedt U, Hegbrant J.

Int J Artif Organs. 1999 Dec;22(12):811-5.

PMID:
10654877
43.

Assessment of pH and oxygen status during hemodialysis using the arterial blood line in patients with an arteriovenous fistula.

Nielsen AL, Thunedborg P, Brinkenfeldt H, Hegbrant J, Jensen HA, Wandrup JH.

Blood Purif. 1999;17(4):206-12.

PMID:
10494023
44.

Vitamin C and E as antioxidants in hemodialysis patients.

Hegbrant J, Hultkvist Bengtsson U.

Int J Artif Organs. 1999 Feb;22(2):69-73. Review. No abstract available.

PMID:
10212040
45.

Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: relation to apolipoprotein(a) size polymorphism.

Arnadottir M, Berg AL, Kronenberg F, Lingenhel A, Hugosson T, Hegbrant J, Nilsson-Ehle P.

Metabolism. 1999 Mar;48(3):342-6.

PMID:
10094111
46.

Influence of haemodialysis on plasma total homocysteine concentration.

Arnadottir M, Berg AL, Hegbrant J, Hultberg B.

Nephrol Dial Transplant. 1999 Jan;14(1):142-6.

PMID:
10052494
47.

First clinical experience with a new concentrate system for dialysis with dry sodium chloride.

Alquist M, Attman PO, Ipsen R, Jönsson L, Hegbrant J.

ASAIO J. 1998 Sep-Oct;44(5):M592-5.

PMID:
9804502
48.

Heparin and vasoactive peptides in hemodialysis patients.

Hegbrant J, Ekman R, Thysell H.

Blood Purif. 1998;16(3):135-9.

PMID:
9681155
49.

Generation of nitrate during dialysis as a measure of nitric oxide synthesis.

Mårtensson L, Hegbrant J, Thysell H.

Artif Organs. 1997 Feb;21(2):163-7.

PMID:
9028501
50.

Beneficial effect of cold dialysate for the prevention of hemodialysis-induced hypoxia.

Hegbrant J, Sternby J, Larsson A, Mårtensson L, Lassen Nielsen A, Thysell H.

Blood Purif. 1997;15(1):15-24.

PMID:
9096903

Supplemental Content

Loading ...
Support Center